| David R Peters, MD | |
|
891 Norfolk Sq, Norfolk, VA 23502-3209 | |
| (757) 461-0011 | |
| (757) 461-5762 |
| Full Name | David R Peters |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 891 Norfolk Sq, Norfolk, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083737662 | NPI | - | NPPES |
| 010015553 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101053653 (Virginia) | Secondary |
| 208D00000X | General Practice | 0101053653 (Virginia) | Primary |
| Entity Name | Beach Counseling Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689162547 PECOS PAC ID: 7012267172 Enrollment ID: O20180911001900 |
News Archive
High-calorie, energy-dense foods are constantly available in our modern society. Researchers at the Max Planck Institute for Metabolism Research in Cologne have discovered that a group of nerve cells in the brains of mice promotes the consumption of high-fat food.
BioTrends Research Group, Inc. released Wave 3 of its LaunchTrends®: Feraheme report, the third in a multi-phase syndicated market research project tracking the launch of AMAG's new IV iron product, Feraheme, through the first six months of product availability. Each wave of the report provides quantitative information from 50 unique Nephrologists and qualitative information from a subset of 15. The reports assess trial and use of Feraheme, obstacles to use, reasons to use, typical patient types, product perceptions, promotional efforts/messages, and product satisfaction.
Doctors have used focused ultrasound to destroy tumors in the body without invasive surgery for some time. However, the therapeutic ultrasound used in clinics today indiscriminately damages cancer and healthy cells alike.
In a new study published in the American Association of Cancer Research's journal Cancer Research, a pair of investigators at Rutgers and Columbia universities has identified a gene that may provide a new source of potential drug targets for tumors that arise in pulmonary tuberous sclerosis complex (TSC).
Doctors could soon be administering an entire course of treatment for life-threatening conditions with a 3D printed capsule controlled by magnetic fields thanks to advances made by the University of Sussex researchers.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David R Peters, MD 4729 Haygood Point Rd, Virginia Beach, VA 23455-4725 Ph: (804) 355-4358 | David R Peters, MD 891 Norfolk Sq, Norfolk, VA 23502-3209 Ph: (757) 461-0011 |
News Archive
High-calorie, energy-dense foods are constantly available in our modern society. Researchers at the Max Planck Institute for Metabolism Research in Cologne have discovered that a group of nerve cells in the brains of mice promotes the consumption of high-fat food.
BioTrends Research Group, Inc. released Wave 3 of its LaunchTrends®: Feraheme report, the third in a multi-phase syndicated market research project tracking the launch of AMAG's new IV iron product, Feraheme, through the first six months of product availability. Each wave of the report provides quantitative information from 50 unique Nephrologists and qualitative information from a subset of 15. The reports assess trial and use of Feraheme, obstacles to use, reasons to use, typical patient types, product perceptions, promotional efforts/messages, and product satisfaction.
Doctors have used focused ultrasound to destroy tumors in the body without invasive surgery for some time. However, the therapeutic ultrasound used in clinics today indiscriminately damages cancer and healthy cells alike.
In a new study published in the American Association of Cancer Research's journal Cancer Research, a pair of investigators at Rutgers and Columbia universities has identified a gene that may provide a new source of potential drug targets for tumors that arise in pulmonary tuberous sclerosis complex (TSC).
Doctors could soon be administering an entire course of treatment for life-threatening conditions with a 3D printed capsule controlled by magnetic fields thanks to advances made by the University of Sussex researchers.
› Verified 3 days ago
Dr. Ann Elizabeth Rawlings, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 7510 Major Ave, Norfolk, VA 23505 Phone: 757-489-0703 | |
Dr. Timothy Ray Brooks, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 1721 Admiral Taussig Blvd, Norfolk, VA 23511 Phone: 757-953-9000 | |
Michael A Webb, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 7924 Chesapeake Blvd, Norfolk, VA 23518 Phone: 757-587-1700 Fax: 757-480-1295 | |
Dr. Zachary Ira Albert, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: U S Marine Corps Forces Command Health Services Suppor, 1468 Ingram Street, Norfolk, VA 23551 Phone: 757-836-1685 | |
Dr. Jason Gordon, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Uss George Washington (cvn 73), 1562 Mitscher Ave Suite 250, Norfolk, VA 23551 Phone: 757-836-5929 | |
Dr. Mallory J. Read Jr., M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 551 Warren Cres, Norfolk, VA 23507 Phone: 757-622-8925 | |
Gad Brosch, General Practice Medicare: Not Enrolled in Medicare Practice Location: 239 Duke St, 208, Norfolk, VA 23510 Phone: 757-624-1044 |